PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Classification”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources
PubMed1994

[A new classification for congenital hydrocephalus [perspective classification of congenital hydrocephalus (PCCH)] and postnatal prognosis (Part 3). Neuronal maturation process and prognosis in neonatal hydrocephalus].

Seventy cases of neonatal hydrocephalus were analyzed regarding the prognosis using the newly developed concept, namely "Perspective Classification of Congenital Hydrocephalus [PCCH]". The results revealed that the prognosis of premature-neonatal hydrocephalus is not necessarily poor even in the early periods of the neuronal maturation (PCCH Stage- II/III). It was suggested that the major underlying pathophysiological difference between the premature-neonatal and fetal hydrocephalus in the same stage of neuronal maturation is the intracranial pressure dynamics. It was concluded that the fetal hydrocephalus should be treated in the early period of neuronal maturation as the form of neonatal hydrocephalus to avoid the insult of such high intracranial pressure dynamics in utero.

Fetal Diseases↗
PubMed1995

Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma.

There are a number of systems for diagnosing multiple myeloma, myeloma variants and monoclonal gammopathy of undetermined significance. We compared three systems, those according to Durie and Salmon, to Kyle and Greipp, and to the British Columbia Cancer Agency, using material from a population-based registry of 847 patients with a paraproteinemia or multiple myeloma. Of these, 157 underwent both bone marrow and X-ray examinations and were subsequently included in our analysis. The differences between the systems were small, even though in only 64% of the cases the diagnosis according to all three systems was identical. The system used by the British Columbia Cancer Agency turned out to be the shortest and easiest system reviewed here. We propose a more frequent application of this system instead of the more commonly used Durie and Salmon and Kyle and Greipp criteria.

Adult↗